Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 16,790Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 5Boehringer Ingelheim GmbH

02 16NOVARTIS ANIMAL HEALTH CANADA INC

03 3Smith & Kenner Pharmaceuticals

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

MILBEMYCIN OXIME

Brand Name : NEXGARD SPECTRA

Dosage Form : TABLET (CHEWABLE)

Dosage Strength : 1.9MG

Packaging :

Approval Date :

Application Number : 2473364

Regulatory Info : Prescription

Registration Country : Canada

blank

02

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

MILBEMYCIN OXIME

Brand Name : NEXGARD SPECTRA

Dosage Form : TABLET (CHEWABLE)

Dosage Strength : 3.8MG

Packaging :

Approval Date :

Application Number : 2473372

Regulatory Info : Prescription

Registration Country : Canada

blank

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

MILBEMYCIN OXIME

Brand Name : NEXGARD SPECTRA

Dosage Form : TABLET (CHEWABLE)

Dosage Strength : 7.5MG

Packaging : 03/06/2012

Approval Date :

Application Number : 2473380

Regulatory Info : Prescription

Registration Country : Canada

blank

04

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

MILBEMYCIN OXIME

Brand Name : NEXGARD SPECTRA

Dosage Form : TABLET (CHEWABLE)

Dosage Strength : 15MG

Packaging :

Approval Date :

Application Number : 2473399

Regulatory Info : Prescription

Registration Country : Canada

blank

05

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

MILBEMYCIN OXIME

Brand Name : NEXGARD SPECTRA

Dosage Form : TABLET (CHEWABLE)

Dosage Strength : 30MG

Packaging :

Approval Date :

Application Number : 2473402

Regulatory Info : Prescription

Registration Country : Canada

blank

06

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

MILBEMYCIN OXIME

Brand Name : INTERCEPTOR FLAVOR TABS

Dosage Form : TABLET

Dosage Strength : 11.5MG

Packaging : 06-Dec

Approval Date :

Application Number : 2141418

Regulatory Info : Prescription

Registration Country : Canada

blank

07

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

MILBEMYCIN OXIME

Brand Name : INTERCEPTOR FLAVOR TABS

Dosage Form : TABLET

Dosage Strength : 2.3MG

Packaging : 06-Dec

Approval Date :

Application Number : 2141434

Regulatory Info : Prescription

Registration Country : Canada

blank

08

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

MILBEMYCIN OXIME

Brand Name : INTERCEPTOR FLAVOR TABS

Dosage Form : TABLET

Dosage Strength : 23MG

Packaging : 06-Dec

Approval Date :

Application Number : 2141396

Regulatory Info : Prescription

Registration Country : Canada

blank

09

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

MILBEMYCIN OXIME

Brand Name : INTERCEPTOR FLAVOR TABS

Dosage Form : TABLET

Dosage Strength : 5.75MG

Packaging : 06-Dec

Approval Date :

Application Number : 2141426

Regulatory Info : Prescription

Registration Country : Canada

blank

10

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

MILBEMYCIN OXIME

Brand Name : MILBEMITE

Dosage Form : SOLUTION

Dosage Strength : 0.1%

Packaging : 0.25 ML

Approval Date :

Application Number : 2246889

Regulatory Info : Prescription

Registration Country : Canada

blank

11

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

MILBEMYCIN OXIME

Brand Name : MILBEMAX

Dosage Form : TABLET

Dosage Strength : 4MG

Packaging : 20/50

Approval Date :

Application Number : 2291940

Regulatory Info : Prescription

Registration Country : Canada

blank

12

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

MILBEMYCIN OXIME

Brand Name : MILBEMAX

Dosage Form : TABLET

Dosage Strength : 16MG

Packaging : 20/50

Approval Date :

Application Number : 2291959

Regulatory Info : Prescription

Registration Country : Canada

blank

13

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

MILBEMYCIN OXIME

Brand Name : INTERCEPTOR PLUS

Dosage Form : TABLET

Dosage Strength : 2.3MG

Packaging : 01/06/2012

Approval Date :

Application Number : 2468344

Regulatory Info : Prescription

Registration Country : Canada

blank

14

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

MILBEMYCIN OXIME

Brand Name : INTERCEPTOR PLUS

Dosage Form : TABLET

Dosage Strength : 5.75MG

Packaging : 01/06/2012

Approval Date :

Application Number : 2468352

Regulatory Info : Prescription

Registration Country : Canada

blank

15

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

MILBEMYCIN OXIME

Brand Name : INTERCEPTOR PLUS

Dosage Form : TABLET

Dosage Strength : 11.5MG

Packaging : 01/06/2012

Approval Date :

Application Number : 2468360

Regulatory Info : Prescription

Registration Country : Canada

blank

16

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

MILBEMYCIN OXIME

Brand Name : INTERCEPTOR PLUS

Dosage Form : TABLET

Dosage Strength : 23MG

Packaging : 01/06/2012

Approval Date :

Application Number : 2468379

Regulatory Info : Prescription

Registration Country : Canada

blank

17

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

MILBEMYCIN OXIME

Brand Name : CREDELIO PLUS

Dosage Form : TABLET (CHEWABLE)

Dosage Strength : 2.11MG

Packaging :

Approval Date :

Application Number : 2525674

Regulatory Info : Prescription

Registration Country : Canada

blank

18

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Milbemycin

Brand Name :

Dosage Form : Tablet

Dosage Strength : 5.75MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

19

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Milbemycin

Brand Name :

Dosage Form : Tablet

Dosage Strength : 11.5MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

20

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Milbemycin

Brand Name :

Dosage Form : Tablet

Dosage Strength : 23MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank